Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark consultancy firm, renowned for working with leading pharmaceutical and medical device companies worldwide.
Wed, 02 Apr 2025 02:05:00 GMT For more information, please visit https://polyrizon-biotech.com. This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 ...
